One down, two to go: Medtronic scores small TAVI win against Edwards
This article was originally published in Clinica
Executive Summary
Medtronic has been cleared by a German court of infringing a patent owned by Edwards that relates to transcatheter aortic valve implantation (TAVI) technology. The ruling is a surprising twist in an ongoing battle between the two TAVI rivals; earlier this month, analysts were putting their money on Edwards – the current TAVI leader with Sapien – winning an injunction that would prohibit Medtronic from selling its CoreValve device in Germany (www.clinica.co.uk, 11 June 2013).
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.